Confirm changes
Please review and confirm your changes below.
Please validate captcha
Are you an employee of this fund ?
Add your professional email address below for verification
This email address seems invalid, please retry.
Overview
Who we are | Founded in 2017 in New York, Forepont Capital Partners is a global asset manager in healthcare and life science. We developed strong and tight partnerships with industry leaders: physicians, researchers, key opinion leaders, academia, hospitals and large pharmaceutical groups. |
Value add | Strategy Investing in Bio&Med Tech before the inflection point allows Forepont’s experience, expertise and know-how to have an immediate and unique impact. Our team helps shape the startup to maximise the value creation. Support Our deep knowledge of American and European regulations, structures and markets allows us to provide an important support at local and international levels. |
Firm type | VC |
Global HQ | 1025 Westchester Ave, White Plains, Suite 403 NY10604, USA |
Branch office #1 | |
Branch office #2 | |
Branch office #3 | |
Branch office #4 | |
Branch office #5 |
Thesis
Funding requirements | We invest in start-ups whose science will change the lives of numbers of patients. Forepont philanthropy funds basic and academic research that discovers new science. Our program for medical research is the heart of Forepont. Our funds investment performance is the engine. We continuously deploy resources and expertise around our passion for basic medical research and the performance of our start-ups to participate in the discovery of treatments that will change lives of millions. |
Funding stages | 2. Prototype3. Early Revenue4. Scaling |
Lead | Sometimes |
Check size | $1M to $10M |
Target countries | ![]() ![]() ![]() ![]() |
Portfolio
Settings
How to get in touch | Email address |
Default email or URL to receive deal flow | |
CRM | |
https://www.linkedin.com/company/forepontgrouplp/posts/?feedView=all | |
Website | http://forepont.com |
Loading...
Loading, please wait...Are you sure you want to contact this investor ?